🇺🇸 FDA
Company

Eikon

Eikon Therapeutics

EIKN biotech USA

Quick answer

Eikon is a biotech company (EIKN) headquartered in MILLBRAE, CA, USA with 10 tracked pipeline programs.

Pipeline (10)

project

EIK1001

Advanced Melanoma

Phase 3 · small_molecule · active

1 trials project

EIK1001

Non Small Cell Lung Cancer (Squamous or Non Squamous)

Phase 3 · small_molecule · active

1 trials project

Association atezolizumab + BDB001 + RT

Solid Tumor, Adult

Phase 2 · small_molecule · active

1 trials project

BDB001

Tumor, Solid

Phase 2 · small_molecule · completed

1 trials project

EIK1001

NSCLC

Phase 2 · small_molecule · active

1 trials project

EIK1004-001 (IMP1707-001)

Advanced Solid Tumors

Phase 2 · small_molecule · active

1 trials project

EIK1005

Advanced Solid Tumors

Phase 2 · small_molecule · active

1 trials project

IMP1734

Advanced Solid Tumor

Phase 2 · small_molecule · active

1 trials project

BDB001 (EIK1001)

Tumor, Solid

Phase 1 · small_molecule · completed

2 trials project

BDB018

Tumor, Solid

Phase 1 · small_molecule · completed

1 trials

Patents (4)

patent

US 12370194

Metalloenzyme inhibitor compounds

Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11938134

Metalloenzyme inhibitor compounds

Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11596585

Composition for the prevention of microbial growth

Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 6421455

Method for detecting cancer on skin of humans and mammals and arrangement for pe

Expires Mon Jul 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)